Publications of Gastroenterologist Dr Desmond Wai

Dr Desmond Wai’s  Publications

INVITED SPEAKERS/LECTURERS

  1. Nan-Yang Polytechnics 25 June 2003 Adv Dip in Critical Care 1 hour on the management of Liver cirrhosis
  2. Singapore Hepatitis B Support Group public lecture, 7 Nov 2003, on "choices of treatment for chronic hepatitis B"
  3. NUH Hepatitis B Total Care Patient Education Seminar, 15 Nov 2003, on “Myths and misperceptions on hepatitis B”
  4. Health Promotion Board lecture 29 Jan 2004 “Update on treatment of hepatitis B”
  5. In-Service Education for Nurses Committee. Talk on Treatment of Hepatitis B.
  6. Hep B Total Care Patient Education Seminar, 24 April 2004, Co-chairman of the organizing committee and MC for the event.
  7. Lecture on Colorectal cancer screening at Keppel Shipyard, under Singapore Cancer Society, 14 March 2005
  8. Lecture on Hepatocellular carcinoma, risk factors, at Singapore Chinesee Chamber of Commerce and Industry, under Singapore Hepatitis B Support Group, 2004
  9. Talk on Update on Fatty Liver at Ang Mo Kio Polyclinic on 21 May 2004
  10. Gastroenterology Society of Singapore Symposium on Liver Transplantation 18 Sept 2004 at Sheraton Towers Hotel, Topic: Which patients and when should I refer.
  11. Gastroenenterology Society of Singapore Symposium on Acute liver failure, 27 Nov 2004, NUH
  12. Lecture on Management of upper GI bleeding to Emergency Department, NUH, 11 Feb 2005
  13. NUH GP CME Program, Health Screening: from clinical practice guidelines to clinical practice. 23 July 2005. Speaker and Chairman of the session
  14. Symposium for 35 Indian gastroenterologists and physicians, on Pre and Post Liver Transplant Care, 20 Oct 2005, at NUH
  15. Alexander Hospital Department of Anaesthesia Lecture on Acute liver failure, 12 Jan 2005.
  16. Nanyang Polytechnic School of Health Sciences to students in Advanced Diploma in Nursing, on Liver cirrhosis/liver failure, on 11 February 2005
  17. Nanyang Polytechnic School of Health Sciences to students in Advanced Diploma in Nursing, on Liver cirrhosis/liver failure, on 8 July 2005
  18. Asia-Hep GP CME Talk on Fatty liver disease, 6 Aug 2005, Regent Hotel
  19. Hep B total care, public lecture on Fatty Liver disease, 26 Nov 2005
  20. Nanyang Polyclinic School of Health Sciences to students in Advanced Diploma in Nursing, on Liver cirrhosis and Liver Failure, on 6 Jan 2006
  21. MMED (Occupation Medicine) course 2005-6, lecture on approach to jaundice, 23 Feb 2006
  22. 21st Annual Scientific Meeting of Gastroenterology Society of Singapore, speaker in GP symposium on “approach to abnormal liver function test” Feb 2006
  23. Singapore Hep B support group. Lecture on :Why do I need a liver biopsy?” 30 June 2006.
  24. Asia-Hep GP CME Talk on “Yellow eyes and dark colored urine: a clinical approach”, 12 August 2006
  25. Gastroenterology Society of Singapore (GESS) CME symposium on viral hepatitis, 7 Oct 200, Conrad Centennial Hotel, Talk on “Chronic hepatitis C: whom to treat”
  26. Pakistan Liver Meeting 1-3 Dec 2006, Karachi, Pakistan on “Management of advanced HCC” and “Presumed consent: impact on DDLT”
  27. Indian Medical Association, Chandigarh State Branch. CME on Hepatology: Indications and selection criteria for Liver Transplantation, Chandigarh, India, 6 Dec 2006
  28. Indian Medical Association, Amritsar Branch. CME on Liver Transplant: Selection criteria for liver transplant, Amritsar, India, 7 Dec 2006
  29. 7th International Symposium on Hepatology, Organised by Association of Study of Liver Dhaka, Bangladesh. Living Donor Liver Transplant, 20th Dec 2006
  30. 2nd International Conference of Al Noor Hospital, UAE, Feb 6-8, 2007, speaker on living donor liver transplant symposium
  31. 22nd Annual Scientific Meeting of Gastroenterology Society of Singapore, GP symposium on “Liver Nodule: how to investigate and when to refer”
  32. 4th Egyptian International Conference on Living Donor Liver Transplantation , orgainsed by Dar Al Fouad Hospital, Cairo, Egypt, 18-19 April 2007. “Role of LDLT in management of HCC”, “Management of patients after liver transplant”, “Patient selection for liver transplant”, “State of the Art Lecture: LDLT”
  33. Cambodia & Singapore Exchanges on Advancements in Key Medical Fields Phnom Penh, Cambodia, 22 May 2007 Topic “Living Donor Liver Transplantation”
  34. Mid-Term India Society of Gastroenterology Meeting, Indoor, India, 30 Jun-1 July, 2007
    Topic: “Live Donor Liver Transplant: State of the Art”
  35. Gastro/Hepatology Meeting, Jakarta, Indonesia, 20 July 2007
    Topic: “Patient selection of LDLT and management of post LDLT complication”
  36. Ceylon College of Physicians, 40th Annual Academic Sessions Program
    28 Sept 2007. Topic: “Management of Acute Liver Failure” and “LDLT
  37. The 5th National Scientific Meeting of the Indonesian Society of Internal Medicine, Solo, Indonesia, 5-6 Dec 2007. Topic: “Current Management of endstaged liver disease”
  38. APASL working part on acute on chronic liver failure. Live data share and consensus development conference, 22-23 Jan 2008 Delhli, India. Topics: “ACLF in Singapore” and “Treatment of renal failure in ACLF”
  39. APASL consensus development on liver fibrosis, 29 Jan 2008, Cairo, Egypt. Topic: “APRI in predicting liver fibrosis”
  40. Management of post transplant patients and Management of ascites, June 2008, Jakarta, Indonesia, at Indonesia Association of Study of Liver Disease.
  41. Asia Pacific Digestive Week 2008, Delhi, India. “Cadaeric liver transplant in Asia Pacific Region”
  42. Ceylon College of Physicians, 41th Annual Meeting, 2nd Oct 2008

“Management of a post transplant patient”

  1. Total Wellness Seminar, organized by Singapore Lianhe Zaobao, May 2009

“Hygiene, Gems, and Infection”

  1. Annual Meeting, Ukraine National Medical Academy, 9 April 2010 at Kiev, Ukraine on “Live Donor Liver Transplant: Singapore experience”
  2. "Living Donor Liver Transplant- Singapore Perspective"  in the seminar organized by Bangladesh Organ Transplant Society, 14th May 2010
  3. "Management of chronic hepatitis B and C: What is new in 2010" Seminar organized by the Bangladesh Association for the Study of the Liver, Dhaka, 14th May 2010
  4. “Endoscopy for Liver Emergencies” 1st Hepatology international Conference of the Hepatology Society, Dhaka, Bangladesh. 28 Oct 2010
  5. “Treating hepatitis C in patients with autoimmune diseases” Gastroenterology Society of Singapore Postgraduate Course, Singapore, 25 June 2011
  6. Patient Care & Immunosuppresive Therapy After Liver Transplantation. And Advanced Liver Cirrhosis Patient: When We Decide? Symposia Current Treatment Hepatopancreatobiliary Diseases, organized by Department of Internal  Medicine, University of Indonesia, 29April – 1 May 2011
  7. Viral Hepatitis: Is it more than it seems. Gleneagles Hospital 13th Annual Seminar, 10 July 2011, Goodwood Park Hotel, Singapore
  8. Channelnewsasia Seminar: Who Knows What Lurks in Your Liver and Digestive System? 29 Oct 2011, Marriott Hotel
  9. Management of liver cirrhosis and liver cancer, Dover Park Hospice, 2 Nov 2011
  10. Management of liver cirrhosis, SCIENTIFIC SYMPOSIUM : “THE 2nd - ACHIEVEMENT & CHALLENGE IN HEALTHCARE” organized by HCMC Medical University and Novartis Pharma Service A.G. Vietnam, HCM City, May 2011
  11. Bacterial Infection in cirrhosis and Emerging Concept & Management of Hypotremia &Renal Dysfunction in Liver Cirrhosis : a common feature in clinical practice. LIVER-GI FAIR 2011, Jakarta Sept 2011
  12. Treating hepatitis C patients with autoimmune diseases, Gastroenterology Society of Singapore Postgraduate Course 25 -26 June, 2011, NUS
  13. “Management of Hepatitis B, an update” for the World Hepatitis Day, organized by the Association of the Study of Liver, Dhaka, Bangladesh, 24 July 2011.

Invited Reviewers for peer review scientific journals

  1. Journal of Viral hepatitis JVH-00101-2005
  2. Hepatology HEP-05-0285
  3. Singapore Medical Journal 218092004 
  4. QJM QJM-D-05-00043
  5. Singapore Medical  Journal 114042005
  6. Hepatology 2005-05-0704
  7. Hepatology 2005-05-1338
  8. Hepatology 2005-05-1530
  9. American Journal of Transplant AJT-C-05-01202
  10. Singapore Medical Journal 326092005
  11. Hepatology 2006-06-0176,
  12. Liver International  LIVint-06-00014
  13. Singapore Medical Journal 403-112005
  14. Singapore Medical Journal 24172005
  15. Singapore Medical Journal SMJ-2006-55
  16. Singapore Medical Journal SMJ-2006-193
  17. Annals of Internal Medicine M06-1806
  18. European Surgical Research 2006-10003
  19. Singapore Medical Journal SMJ 2006-591
  20. Liver International LIVint-06-00487
  21. Liver International LIVint-07-00048
  22. Journal of Gastroenterology Hepatology JGH-00452-2007
  23. Journal of Gastroenterology Hepatology JGH-01253-2007
  24. Journal of Gastroenterology Hepatology JGH-00140-2008
  25. Annals of Internal Medicine MS#M08-0784
  26. Journal of Gastroenterology Hepatology JGH-00257-2008.R1
  27. Hepatology International HEPI-D-09-00051
  28. Journal of Gastroenterology Hepatology JGH-00962-2008
  29. Journal of Gastroenterology Hepatology JGH-00895-2008
  30. Journal of Gastroenterology Hepatology JGH-01020-2008
  31. Hepatology 09-0257
  32. Singapore Medical Journal SMJ-2010-104
  33. Singapore Medical Journal SMJ 2010-309(1)
  34. Liver International LIVint-10-00704
  35. Journal of Gastroenterology JGH-01232-2010
  36. Journal of Gastroenterology JGH-01145-2010
  37. Singapore Medical Journal SMJ-2010-581.
  38. Singapore Medical Journal SMJ-2010-649
  39. Journal of Gastroenterology Hepatology JGH 0034-2011
  40. Singapore Medical Journal SMJ-2011-474
  41. Annals of Internal Medicine M11-1916

TEXTBOOKS

  1. Management of Common Gastroenterological Problems, A Malaysia and Singapore perspective. 4th Editio 2006. Publisher EzyHealth. Chapter 25, p296-302. Screeningand the early detection of gastrointestinal cancer: KG Yeoh and Desmond Wai
  2. Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases. Elsevier Publisher. First Edition 2009. Chapter 33, p383-384 Drug induced liver injury: Desmond Wai
  3. Comprehensive textbook of Hepatitis B. Jaypee Brothers Medical Publishers (P) Ltd. First Edition 2011. Chapter 16, Hepatitis B in Pregnancy, Desmond Wai and KC Tan

PUBLICATIONS: Manuscripts in peer-review journals

International Publications

  1. Wai CT, Lim SG, Tan KC. Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore. Gut 2000;47:741.
  2. Wai CT, Lo SK, Lee KH, Tan CK, Isaac J, Prabhakaran K, Lim SG, Tan KC. Liver transplantation in hepatocellular carcinoma. Transplant Proc 2000;32:2173.
  3. Wai CT. Lo SK, Lee KH, Tan CK, Aw MM, Quak SH, Isaac J, Prabhakaran K, Lim SG, Tan KC. 10 years of experience of liver transplantation in Singapore. Transplant Proc. 2000 ;32:2139.
  4. Lee KH, Wai CT, Lim SG, Quak SH, Manjit K, Lee HL, Da Costa M, Tan KC. Risk of de-novo hepatitis B from anti-HBc positive donors in liver transplantation in Singapore. Liver Transplantation 2001;7:469-70.
  5. Wai CT, Lim SG, Tan KC. Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore. Gut 2001;48:581.
  6. Wai CT, Ho KY, Yeoh KG, Lim SG. Palliation of malignant gastric outlet obstruction with expansile metal stents. Surgical Laparoscopy, Endoscopy and Percutaneous Techniques. 2001;11:161-4.
  7. Wai CT, Tambyah PA. False positive HIV-1 Elisa in patients with hepatitis B. American Journal of Medicine 2002;112:737.
  8. Lim SG, Wai CT, Guan R, Rajnavoka A, Kaijiji T. Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B. Gut 2002;51:597-9.
  9. Wai CT, Yeoh KG, Ho KY, Kang JY, Lim SG. Endoscopic yield in Asian patients presenting with dyspepsia. Gastrointerstinal Endoscopy 2002;56:548-51.
  10. Lim LL, Wai CT, Lee YM, Kong HL, Lim R, Koay E, Lim SG. Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients. Aliment Pharmacol Ther 2002;16:1939–1944.
  11. Wai CT, Yeoh KG, Ho KY. Esophageal intubation with duodenoscope in the presence of pharyngeal pouch by a guidewire and catheter technique. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2002. Surgical Laparoscopy Endoscopy & Percutaneous Techniques 2002;12:362-363.
  12. Wai CT, Lok ASF. Treatment of hepatitis B. J Gastroenterol 2002;37:771–778.
  13. Wai CT, Chu CJ, Hussain M, Lok AS. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology 2002;36:1425-30
  14. Wai CT, Tan LH, Kaur M, Da Costa M, Quak SH, Tan KC. Pitfalls in interpreting liver biopsy results: the story of the blind men and the elephant. Liver Transplantation 2002;8:1200-1.
  15. Wai CT, Fontana RJ. Genetic polymorphisms in chronic hepatitis B: a step up the cytokine ladder. Am J Gastroenterol 2003;98:6-8.
  16. Wai CT, Ho KY, Kwok FY. Esophageal dislodgement of variceal ligator cap due to mismatch of sizes between the ligator cap and the endoscope. Endoscopy 2003;35:191.
  17. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS.  A Simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-26.
  18. Wai CT, Ho KY. Reply to syn et Al. Endoscopy. 2003;35:796-7.
  19. Wai CT, Lok ASF. Reply. Hepatology 2003;38:1313.
  20. Lok ASF, Wai CT. Reply. Hepatology 2004;39:863.
  21. Wai CT, Lok ASF. Reply. Hepatology 2004;39:1457-8.
  22. Wai CT, Fontana RJ. Clinical significance of HBV genotypes, variants, and mutants. Clinics in Liver Diseases 2004;8: 321-52.
  23. Wai CT. Clinical vigilance is as important as prophylactic antiobiotics in cirrhotic patients undergoing GI endoscopy. Gastrointest Endoscopy 2004;60:671-2.
  24. Wai CT, Prabhakaran K, YM Lee, Dan YY, Sujtedja DS, Isaac J, Lee KH, Lee HL, Lee M, Da Costa M, Lim SG. Adefovir dipivoxil (ADV) as the rescue therapy for lamivudine (LAM) resistant hepatitis B post liver transplant . Transplantation Proceedings 2004;36:2313-4.
  25. Wai CT, K Prabhakaran, M Kaur, Lee YM, Dan YY, Sutjedta D S, MM Aw, Quak SH, Mak K, Isaac J, KH Lee, SG Lim. Successful listing of patients for liver transplant was related to paricipation of referring doctor in the transplant program. Transplantation Proceedings 2004;36:2230-1.
  26. Sutedja D S, Wai CT, Teoh KF , Lee HL , DaCosta M, Lee M, Kaur M, Lee YM, Mak K, Isaac J, Lee KH, Lim SG, Prabhakaran K. Persistent thrombocytopenia in liver transplanted patients. Transplantation Proceedings 2004;36:2331-3
  27. Sutedja D S, Wai CT, Teoh KF , Lee HL , DaCosta M, Lee M, Kaur M, Lee YM, Mak K, Isaac J, Lee KH, Lim SG, Prabhakaran K. Renal impairment and diabetes mellitus after liver transplantation. Transplantation Proceedings 2004;36:2324-7.
  28. Wai CT, Fontana RJ, Polson J, Hussain M, Shakil AO, Han SH, Davern TJ, Lee WM, Lok ASF, and the U.S. Acute Liver Failure Study Group. Clinical Outcome and Virological Characteristics of Acute Hepatitis B Infection in the United States. J Viral Hepatitis 2005; 12, 192–198
  29. Wai CT, Sutedja DS, Khor C, Teoh KF, Yeoh KG. Esophageal sinus formation as a complication of cyanoacrylate injection. Gastrointest Endoscopy 2005;61:773-5.
  30. Wai CT, Sutedja SD, Lee YM. Remember to Crush the Tablets after Esophageal Stent Insertion. Surgical Laparoscopy, Endoscopy and Percutaneous Techniques 2005;15:22-3.
  31. Wai CT, Khor C, Lim SE, Ho KY. Post-metallic stent placement bleeding caused by stent-induced ulcers. World J Gastroenterology 2005;11:5739-41
  32. Dan YY, Wai CT, Lee YM, Sutedja DS, See BL, Lim SG. Outcome of lamivudine resistant hepatitis B virus is generally benign except in cirrhotics. World J Gastroenterology 2005;11: 4344-50.
  33. Wai CT, Mak B, Chua W, Tan MH, Ng S, Cheok A, Wong ML, Lim SG. Misperceptions among patients with chronic hepatitis B in Singapore. World J Gastroenterology 2005 2005;11:5002-5005
  34. Wai CT, Wong ML, Ng S, Cheok A, Tan MH, Chua W, Mak B, Lim SG. Utility of the health belief model in predicting compliance of screening in patients with chronic hepatitis B.  Aliment Pharmacol Ther 2005;21:1255-62.
  35. Ho KY, Gwee KA, Khor CJ, Sutedja DS, Wai CT, Yeoh KG. Empiric treatment for the management of patients presenting with uninvestigated reflux symptoms: a prospective study in an Asian primary care population. Aliment Pharmacol Ther 2005;21:1313-20.
  36. Fernandes ML, Lee YM, Sutedja D, Wai CT, Isacc J, Prabhakaran K, Lim SG, Lee KH. Treatment of steroid-resistant acute liver transplant rejection with basiliximab. Transplant Proc 2005;37:2179-80
  37. Lee YM, Wai CT, Da Costa M, Lee KH, Sutedja D, Tan KC, Isaac J, Lim SG. Bilirubin appears to be the only independent variable affecting mortality on liver transplant waiting list if waiting time exceeds 1 year. Transplant Proc 2005;37:4365-6.
  38. Wai CT, Cheah WK. An unusual case of abdominal pain. J Gastroenterology Hepatology Gastrointestinal: Midgut malrotation in an adult. J Gastroenterol Hepatol 2006;21:917.
  39. Dan YY, Wai CT, Yeoh KG, Lim SG. Prophylactic Strategies for Hepatitis B patients undergoing liver transplant: A Cost-effectiveness Analysis. Liver Transplantation 2006;12:736-46.
  40. Lim SG, Wai CT, . A clinical trial of thymosin alpha-1 and interferon alpha in therapy of HbeAg positive chronic hepatitis B: Results of a multicenter randomized controlled study. Antivir Ther. 2006;11:245-53.
  41. Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Aung MO, Lim SG.  Non invasive models for predicting histology in patients with chronic hepatitis B.  Liver International 2006: 26: 666–672.
  42. Low HC, Da Costa M, Prabhakaran K, Manjit K, Wee A, Lim SG, Wai CT. Impact of a new legislation on presumed consent on organ donation on liver transplant in Singapore: a preliminary analysis. Transplantation 2006;81:1234-37
  43. Wai CT, Lim SG, Aung, MO, Lee YM, Sutedja DS, Dan YY, Aw MM, Quak SH, Lee MK, Da Costa M, Prabhakaran K, Lee KH. MARS: a futile tool in centers without active liver transplant support. Liver Int. 2007 Feb;27(1):69-75.
  44. Lim LG, Cheng CL, Wee A, Lim SG, Lee YM, Sutedja DS, Da Costa M, Prabhakaran K, Wai CT. Prevalence and clinical associations of post-transplant fatty liver disease. Liver Int. 2007 Feb;27(1):76-80.
  45. Wong SN, Chu CJ, Wai CT, Howell T, Moore C, Fontana RJ, Lok AS. Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy. Liver Transpl. 2007 Mar;13(3):374-81.
  46. Wai CT, Aung MO, Mak B, Lim SG. Age in guiding strategy of hepatitis A vaccination. Am J Med. 2007 Aug;120(8):e17-8.
  47. Wai CT, Tan S, Alburque H, Sutedja DS. Structured, supervised ambulatory medical education for junior doctors. Medical Teacher 2006 Dec;28(8):747.
  48. Wai CT, Tan BH, Chan CL, Sutedja DS, Lee YM, Khor C, Lim SG. Drug induced liver failure in Asia: a prospective study. Liver Int. 2007 May;27(4):465-74.
  49. Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC. Long Term Outcome and Prognostic Factors for Large Hepatocellular Carcinoma (10 cm or more) after Surgical Resection. Ann Surg Oncol. 2007;14(10):2817-23.
  50. Wong RKM, Lim SG, Wee A, Chn YH, Aung MO, Wai CT. Primary biliary cirrhosis in Singapore: Evaluation of demography, prognostic factors and natural course in a multiethnic population. J Gastroneterol Hepatol 2007;Jul 20; [Epub ahead of print]
  51. Wong ML, Fones CS, Aw M, Tan CH, Low PS, Amin Z, Wong PS, Goh PS, Wai CT, Ong B, Tambyah P, Koh DR. Should non-expert clinician examiners be used in objective structured assessment of communication skills among final year medical undergraduates? Med Teach. 2007 Nov;29(9):927-32.
  52. Thamboo PB, Wai CT, Lim LG, Wang SC. Gastric ulcer with embolised microspheres and cytomegalovirus infection following Selective Internal Radiation Therapy (SIRT) of the liver. Pathology. 2008 Mar;40(3):303-5.
  53. Wai CT, Lee KH, Tan KC. Prophylactic variceal ligation is not recommended for patients awaiting live donor liver transplant. Liver Transpl. 2008 Apr;14(4):580
  54. Lee YM, Wai CT, et al. A randomized controlled pilot study of Pentoxifylline in patients with Non Alcoholic Steatohepatitis (NASH). Hepatology International 2008;2:196-201
  55. Wai CT, M Lin, Tan KC. Pulmonary embolism with lipoidal after variceal injection. J Gastroenterol Hepatol 2008;23(8 Pt 1):1306.
  56. Rajekar H, Wai CT, Lee KH, Wong SY, Tan KC. Spontaneous bacterial peritonitis from Salmonella: an unusual bacterium with unusual presentation. Hepatology International 2008;2:388-389
  57. Majeed TA, Wai CT, Rajekar H, Lee KH, Wong SY, Leong SO, Singh R, Tay KH, Chen J, Tan KC. Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation. Transplant Proc. 2008 Oct;40(8):2507-9.
  58. Rajekar H, Wai CT, Majeed TA, Lee KH, Wong SY, Leong SO, Singh R, Tay KH, Soosaynathan C, Tan KC. Prognostic factors in patients with acute liver failure undergoing live donor liver transplantation. Transplant Proc. 2008 Oct;40(8):2492-3.
  59. Pandey D, Wai CT, Lee KH, Tan KC. Living donor liver transplantation for hepatocellular carcinoma: A single centre experience. Indian J Gastroenterol. 2008 Jul-Aug;27(4):148-52.
  60. Lim LG, Yeoh KG, Wai CT. Metastatic pancreatic cancer presenting as a bleeding duodenal ulcer 30 months after initial diagnosis of duodenal ulcer. Should duodenal ulcers be biopsied or followed up with repeat endoscopy? Acta Gastroenterol Belg. 2008 Jul-Sep;71(3):347-8.
  61. Shiv Kumar Sarin, Ashish Kumar, John A. Almeida, Yogesh Kumar Chawla, Sheung Tat Fan, Hitendra Garg, H. Janaka de Silva, Saeed Sadiq Hamid, Rajiv Jalan, Piyawat Komolmit, George K. Lau, Qing Liu, Kaushal Madan, Rosmawati Mohamed, Qin Ning, Salimur Rahman, Archana Rastogi, Stephen M. Riordan, Puja Sakhuja, Didier Samuel, Samir Shah, Barjesh Chander Sharma, Praveen Sharma, Yasuhiro Takikawa, Babu Ram Thapa, Chun-Tao Wai and Man-Fung Yuen Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatology International 2009;3:269-282
  62. Gamal Shiha, Shiv Kumar Sarin, Alaa Eldin Ibrahim, Masao Omata, Ashish Kumar, Laurentius A. Lesmana, Nancy Leung, Nurdan Tozun, Saeed Hamid, Wasim Jafri, Hitoshi Maruyama, Pierre Bedossa, Massimo Pinzani, Yogesh Chawla, Gamal Esmat, Wahed Doss, Taher Elzanaty, Puja Sakhuja, Ahmed Medhat Nasr, Ashraf Omar, Chun-Tao Wai, Ahmed Abdallah, Mohsen Salama, Abdelkhalek Hamed, Ayman Yousry, Imam Waked, Medhat Elsahar, Amr Fateen, Sherif Mogawer, Hassan Hamdy, Reda Elwakil and Jury of the APASL Consensus Development Meeting 29 January 2008 on Liver Fibrosis With Without Hepatitis B or C. Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) . Hepatology International 2009;3:323-33
  63. Wai CT, Ngoi SS, Peter G, Lee KH, Lin M, Tan KC. Modified rendezvous technique in management in biliary leak in right lobe live donor liver transplant recipients. Surgical, Laparoscopy, Endoscopy, Percutaneous Techniques 2009 ; 19(4):e143-5.
  64. Christopher Lim, Desmond Wai, Lee KH, Tan KC. Current and emerging treatments for cjholangiocarcinoma. International Journal of Hepatology 2010;1(4): 22-35
  65. Desmond  Wai. Update on management of viral hepatitis B. Euroasian Journal of Hepato-Gastroenterology, 2011;1(2): 40-52
  66. Wai CT, Woon WA, Tan YM, Lee KH, Tan KC. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation. Transplant Proc. 2012 Mar;44(2):516-9.
  67. Wai CT, Woon WA, Tan YM, Lee KH, Tan KC. Pretransplant Model for End-stage Liver Disease Score Has No Impact on Posttransplant Survival in Living Donor Liver Transplantation.  Transplant Proc. 2012 Mar;44(2):396-8.
  68. Lim C, Wai D, Lee KH, Tan KC. Current and Emerging Treatment for Cholangiocarcinoma. International Journal of Hepatology 2010:1:25-35
  69. Wai D. Euroasian Journal of Hepato-Gastroenterology 2011;1:49-52
  70. Wai CT. Correcting thrombocytopenia in patients with liver diseases: a difficult hurdle. J Gastroenterol Hepatol. 2013 Feb;28(2):207-8

 

Local Publications

  1. Wai CT, Mak B, Chua W, Lim SG. The majority of hepatitis B carriers are not on regular surveillance in Singapore. Singapore Medical Journal 2004;45:423-6.
  2. Lu W, Wai CT, Da Costa M, Tambyah PA, Prabhakaran K, Lee KH. Tuberculosis post liver transplantation: a rare but complicated disease. Annals of Academy of Medicine, Singapore 2005;34:213-5.
  3. Wai CT, Lau G, Sutedja DS. Clinics in diagnostic imaging (104): Gastric trichobezoar (or hairball). Singapore Med J 2005;46:359-62.
  4. Wai CT, Lau G, Khor C. Clinics in diagnostic imaging (105): Sigmoid volvulus causing intestinal obstruction, with successful endoscopic decompression. Singapore Medical Journal 2005;46:483-7.
  5. Wai CT. Presentation of drug induced liver injury in Singapore. Singapore Medical Journal 2006;47(2):116-120
  6. Lu W, Wai CT. Surgery in patients with advanced liver cirrhosis: a pandora’s box. Singapore Medical Journal 2006;47(2):152-155.
  7. Wai CT, et al. Liver transplantation in Singapore 1999-2004. Singapore Med J 2006;47(7):580-3.
  8. Wai CT, et al. Liver transplantation for hepatocellular carcinoma in Singapore. Singapore Med J 2006 Jul;47(7):584-7.
  9. Wai CT, et al. Long-term results of liver transplant in patients with chronic viral hepatitis related liver disease in Singapore. Singapore Med J 2006 Jul;47(7):588-91.
  10. Sutedja D S, Wai C T, Teoh K F, Lee Y M, Diddapur R K, Isaac J, Mak K, Da Costa M, R N, Lee K H, Prabhakaran K, Tan K C, Lim S G. Long-term post-liver transplant complications of renal impairment and diabetes mellitus – data from Singapore. Singapore Medical Journal 2006 Jul;47(7):604-8.
  11. Lim S G, Wai C T, Da Costa M, Sutedja D S, Lee Y M, Lee K H, Tan C K, Prabhakaran K, Tan K C, Isaac J Referral patterns and waiting time for liver transplantation in Singapore. Singapore Medical Journal 2006;47(7):599-603.
  12. Wong RKM, Wai CT. Dyspnoeic after plasma transfusion- a case of transfusion-related acute lung injury. Singapore Med J 2006 47(10):904-6
  13. Wong RKM, Wai CT. A bolt out of the blue: a case of unexpected acute liver failure. Annals of Academy of Medicine, Singapore 2006;35:504-7.
  14. Pan JY, Seto KY, Wai CT. Clinics in diagnostic imaging. Acute abdomen in a young man with chronic hepatitis B SMJ 2007; 48 (5) 469-474
  15. Wai CT, Seto KY, Sutedja DS. Clinics in diagnostic imaging. A middle aged woman presenting with obstructive jaundice. Singapore Med J. 2007 Apr;48(4):361-6
  16. Lu W, Mak B, Lim SG, Aung MO, Wong ML, Wai CT. Public misperceptions about transmission of hepatitis B virus in Singapore. Ann Acad Med Singapore. 2007 Oct;36(10):797-800.
  17. Yeo WT, Tan KL, Dan YY, Wai CT. Delayed bleeding after liver biopsy: a dreaded complication. Singapore Med J 2008;49:76-80.
  18. Chang SK, Chan CL, Yu RQ, Wai CT. Mimicry of acute cholecystitis from Wilson's disease Singapore Med J. 2009 Mar;50(3):e102-4.
  19. Wai CT. Alpha-foetoprotein: an inaccurate test for surveillance of post-treatment recurrence of hepatocellular carcinoma. Singapore Med J. 2012 Apr;53(4):29

 

PUBLICATIONS: Abstracts

  1. Wai CT, Lim SG, Lee KH, Chow WC, Tan CK, Isaac J, Prabhakaran K, Tan KC. Use of lamivudine in hepatitis B patients undergoing liver transplantation. Gastroenterology 2000;118(4):A1497.
  2. Lim SG, Wai CT, Ding R, Guan R. Fatal reactivation of hepatitis B after withdrawal of nucleoside analogues. Gastroenterology 220;118(4)A1464.
  3. Wai CT, Yeoh KG, Ho KY, Lim SG. Endoscopic yield in Asian patients presenting with dyspepsia. Gastrointestinal Endoscopy 2000;51(4):AB76.
  4. Lee HL, Wai CT, Mak K. Post-operative follow-up of living-related liver transplant donors in Singapore. Hepatology 2000;32(4Pt2):446A
  5. Lim SG, Zhou L, Li L, Tan TMC, Peter F, Ren EC, Delamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Chan SH. An increase in T cell activation and T cell cytotoxic subsets are discriminators of response to treatment with interferon.thymosin in patients with chronic hepatitis B. Hepatology 2000;32(4Pt2):452A
  6. Lim LL, Wai CT, Lee YM, Pereumal, Chung CK, Koay E, Lai ST, Kong HL, Lim SG. Prophylactic lamivudine prevents hepatitis B reactivation and mortality in patients receiving immunosuppression and chemotherapy. Hepatology 2000;32(4Pt2):455A
  7. Lim SG, Zhou L, Li L, Tan TMC, Peter F, Ren EC, Delamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Chan SH. An increase in T cell activation and T cell cytotoxic subsets are discriminators of response to treatment with interferon.thymosin in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2000;15(S):J7
  8. Peter F, Cheng Y, Ong C, Kausalita PJ, Seet BL, Wai CT, Tan T, Lim SG. Hepatitis B e-seroconversion correlates with clustered changes in the core promoter and enhancer II region of HBV. Journal of Gastroenterology and Hepatology 2000;15(S):J45
  9. Lim SG, Zhou L, Li L, Tan T, Ren EC, Selamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Peter F. Increased T cell proliferation to HBs, HBC, HBE-antigens are distriminators of response to treatment with interferon/thymosin in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2000;15(S):J52
  10. Peter F, Cheng Y, Ong C, Kausalita PJ, Seet BL, Selamat DS, Wai CT, Tan T, Lim SG. No correlation between hepatitis B virus e-seroconversion and hot-spot mutation in core promoter and precore sequence of HBV. Journal of Gastroenterology and Hepatology 2000;15(S):J70
  11. Lim SG, Perumal V, Peter F, Tan T, Lee YM, Selamat DS, Wai CT, Lim LL, Leow CL, Chiu L, Kooh MJ, Koay E. Performance of the Digene hybrid capture HBV DNA assay compared to Abbott hybridization HBV DNA assay, and development of a conversion formula. Journal of Gastroenterology and Hepatology 2000;15(S):J77.
  12. Lim LL, Wai CT, Lee YM, Pereumal, Chung CK, Koay E, Lai ST, Kong HL, Lim SG. Prevention of hepatitis B reactivation and mortality in patients receiving immunosuppression and chemotherapy with prophylactic lamivudine. Journal of Gastroenterology and Hepatology 2000;15(S):J80.
  13. Lim SG, Zhou L, Li L, Tan T, Peter F, Ren EC, Selamat DS, Wai CT, Lim LL, Lee yM, Perumal V, Chan SH. T cell cytokine release to HBs, HBc and Hbe antigens before and after treatment with interferon/thymosin in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2000;15(S):J90.
  14. Lee YM, Selamat DS, Wai CT, Lim LL, Dong F, Perumal V, Chung CK, Lim TP, Ho I, Yeoh KG, Ho KY, Lim SG. The natural history fo anti-Hbe +ve chronic hepatitis B patients. Journal of Gastroenterology and Hepatology 2000;15(S):J97.
  15. Wai CT, Chan E, Lee YM, Lim LL, Lim SG. Prognostic factors for acute exacerbaton of chronic hepatitis in Asian patients. Journal of Hepatology 2001;34(S1):135.
  16. Lim S, Zhou L, Tan L, Peter F, Ren E, Selemat DS, Wai C, Lee Y, Lim L, Chan S. T cell immune response during HbeAg seroconversion? Evidence of T cell activation, cytotoxicity and proliferation during treatment with interferon/thymosin in patients with chronic hepatitis B.  Journal of Hepatology 2001;34(S1):118.
  17. Wai CT, Lim SG, Lee KH, Tan CK, Chow WC, Isaac J, Prabhakaran K, Tan KC. Use of lamivudine in prevention of hepatitis B recurrence post liver transplant. J Gastro and Hepatol 2001;16 (4):A7.
  18. Wai CT, Lim SG, Lee KH, Tan CK, Chow WC, J Isaac, Prabhakaran K, Tan KC. Liver transplantation as the treatment of choice for hepatocelular carcinoma. J Gastro and Hepatol 2001;16 (4):A7.
  19. Wai CT, Tan CK, Chow WC, Aw MM, Quak SH, Isaac, Prabhakaran K, Tan KC. Analysis of mortality of liver transplantation. J Gastro and Hepatol 2001;16 (4):A7.
  20. Manjit K, Wai CT, Lee KH, Lim SG, Isaac J, Prabhakaran K Tan KC. Results of hepatitis C in liver transplant patients. J Gastro and Hepatol 2001;16 (4):A7.
  21. Wai CT, Ho KY, Leong A, Kum CK. Stent Migration as a potential complication of metallic stent placement in patients with inoperable colorectal cancer. J Gastro and Hepatol 2001;16 (Suppl):
  22. Wai CT, Teh M, Seet BL, Ho B, Yeoh KG. Helicobacter pylori is directly involved in inflammatory gastric mucosa damage throughout the nitric oxide pathway but not directly related to apoptosis. J Gastro and Hepatol 2001;16 (Suppl):A119
  23. Gwee KA, Wai CT Wong ML, Goh LG. Epidemiology of irritable bowel syndrome in an Asian urban society. J Gastro and Hepatol 2001;16 (Suppl):A12
  24. Wai CT, Gwee KA, Goh LG, Mak B. Treatment expectations, satisfaction and preferences of IBS patients seen by general practitioners. J Gastro and Hepatol 2001;16 (Suppl):A27
  25. Wai CT, DaCosta M, Lim SG, Tan KC, Lee KH. Liver dialysis in Singapore. J Gastro and Hepatol 2001;16 (Suppl):A73
  26. Dan YY, Lee YM, Lim LL, Wai CT, Lim SG. Clinical pathogenicity of lamivudine resistant hepatitis B virus is related to the pre-treatment (wildtype) status. J Gastro and Hepatol 2001;16 (Suppl):A56
  27. Lee YM, Suteja DD, Wai CT, Wong LS, Chan E, Lim SG. The natural history of HbeAg positive and anti-Hbe positive chronic hepatitis B patients – a long term study. J Gastro and Hepatol 2001;16 (Suppl):A270
  28. Wai CT, E Chan, Lee YM, Lim LL, Lim SG. Rising prothrombin time is the sole prognostic factor for flare of chronic hepatitis B in Asian patients. Hepatology 2001;34(4Pt2):198A.
  29. Lim  SG, Zhou L, Li L, Tan T, Frank P Ren EC, Sutedja DS, Wai CT, Lim LL, Lee YM, Dan YY, Perumal V. Differences in baseline immunological parameters between responders and non-responders to interferon/thymosin therapy for chronic HBV. Hepatology 2001;34(4Pt2):623A.
  30. Wai CT, Chu CJ, Hussain M, Lok A. HBV genotype B is associated with a higher response rate to interferon therapy than genotype C. Herpatology 2002;36(2Pt2):221A
  31. Chu CJ, Fontana R, Moore C, Wai CT, Punch J, Su G, Lok A. Efficacy of HBIG weaning in the long-term prophylaxis of HBV reinfection following liver transplantation. Herpatology 2002;36(2Pt2):301A
  32. Wai CT, Perumal V, Mah B, Chua W, Lam C, Lim SG. Screening of chronic hepatitis B carriers in an endemic area is cost-effective in diagnosing long-term complication. Herpatology 2002;36(2Pt2):713A
  33. Yeoh KG, Wai CT, Teh M, Rajnakova A. Gastric cancer is associated with reduced apoptosis in non-lesional gastric mucosa irrespective of Helicobacter pylori infection. Int J Cancer 2002;Suppl. 13:190-191.
  34. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A non invasive index is useful in excluding both significant fibrosis and cirrhosis in chronic hepatitis C patients. Gastroenterology 2003;124(S1):A777
  35. Yeoh KG, Wai CT, The M, Tan KB, Seet BL, Rajnakova A. Gastric cancer is associated with reduced apoptosis in non-lesional gastric mucosa rather than increased mucosal proliferation. Gastroenterology 2003;124(S1):A463.
  36. Wai CT, Perumal V, Mak B, Chua W, Lam C, Lim SG. Inclusion of young patients in surveillance program for hepatitis B. J Gastroenterol Hepatol 2003;18 (Supp):A107.
  37. Mak B, Wai CT, Chen MH, Lim SG. Informed consent and clinical trials for chronic hepatitis B in Asia: Do patients understand the concepts? Hepatolog 2003;38 (4) (Supp1. 1):693A
  38. Wai CT, Fontana RJ, Schilsky M, McCashland T, Han S,
  39. Polson J, Hussain M, Lee WM, Lok AS. Molecular epidemiology of hepatitis B virus-related acute liver failure in the United States: a multicenter case control study. Hepatology 2003;38 (4) (Suppl. 1):555A
  40. Wai CT, Mak B, Chua W, Lim SG. Screening of compliance among hepatitis B carriers in Singapore. J Gastroenterol Hepatol 2004;19 (Suppl) A298.
  41. Lu W, Wai CT, Da Costa M, Tambyah PA, Prabhakaran K, Lee KH. Tuberculosis post liver tranplantation: a rare but complicated disease. Annals of Academy of Medicine, Singapore 2004; 33:S158.
  42. Lu W, Wai CT, Da Costa, Tambyah PA, Prabhakaran K, Lee KH. A case report on tuberculosis post liver transplantation. J Gastroenterol Hepatol 2004;19 (Suppl): A842
  43. Wai CT, Sutedja D, Da Costa M, Lee YM, Isacc J, Prabhakaran K, Lim SG. Long-term results of liver transplant in patients with chronic viral hepatitis and related liver diseases. J Gastroenterol Hepatol 2004;19 (Suppl): A778
  44. Wai CT, Lim SG. Herbal medicines is an important cause for drug induced liver injuries (DILI). J Gastroenterol Hepatol 2004;19 (Suppl): A755
  45. Teoh KF, Wai CT, Aung MO, Da Costa M, Lee HL, Isaac J, Lim SG. Epidemiology of acute liver failure in Singapore. J Gastroenterol Hepatol 2004;19 (Suppl): A829.
  46. Lai CL, Brown NA, Yuen MF, Wai CT, Lloyd D, Pietropaolo K, Zhou XJ, Chao G, Lim SG. Valtorcitabine provides potent suppression of hepatitis B virus in patients with chronic hepatitis B: Results of a phase I/II clinical trial. Hepatology 2004;40 (Suppl 1): 173A.
  47. Lim SG, Teoh KF, Wai CT, Aung MO, Da Costa M, Isaac J. Epidemiology of acute liver failure in Singapore. Gut 2005;185 Suppl 2:A49.
  48. Lim SG, Lai CL, Myers M, Yuen MF, Wai CT, Lloyd D, Pietropaolo K, Zhou XJ, Chao G, Brown NA. Final results of a phase I/II dose escalation trial of valtorcitabine in patients with chronic hepatitis B. J Hepatology 2005; 42 Suppl 2:16
  49. Wai  CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Aung MO, Lim SG. A Novel Non Invasive Marker Can Exclude Cirrhosis in Chronic Hepatitis B.
  50. Teoh KF, Wai CT, Da Costa M, Isaac J, Lim SG. Drug induced liver failure in Asia. Gastroenterology 2005;128:A706.
  51. Chun-Tao Wai, How-Cheng Low, Maureen Da Costa, John Isaac and Seng-Gee Lim. Impact of new legislation on the number of liver transplants in Singapore. J Gastroenterol Hepatol 2005;25:1332 A282.
  52. RKM Wong, SG Lim, YH Chan, MO Aung, CT Wai. Primary biliary cirrhosis in an Asian population: a natural history study. J Gastroenterol Hepatol 2005;25:1320 A232.
  53. Wai CT, Mak B, Aung MO, Lim SG. Age as a determinant on test-and-vaccinate vs. vaccinate-all for hepatitis A immunization. J Gastroenterol Hepatol 2006;21(Supp 1):A24.
  54. Sutedja D, Wai CT, Teoh KF, Lee YM, Isaac J, Prabhakaran K, Lim SG. Long term post liver transplant complications- data from Singapore. Annals of Academy of Medicine, Singapore 2005;34:S85
  55. Teoh KF, Wai CT, Aung MO, Da Costa M, Lim SG. Epidemiology of acute liver failure in Singapore. Annals of Academy of Medicine, Singapore 2005;34:S85
  56. Wai CT. Presentation of drug induced liver injury in Singapore. Annals of Academy of Medicine, Singapore 2005;34:S85
  57. Wai CT, Lim LG, Low HC, Da Costa M, Isaac J, Lim SG. Impact of new legislation on the number of liver transplant in Singapore. Annals of Academy of Medicine, Singapore 2005;34:S85
  58. Wai CT, Lim LG, Wang SC, Lee YM, Isaac J, Wee A, Lim SG. Liver transplantation for hepatocellular carcinoma in Singapore. Annals of Academy of Medicine, Singapore 2005;34:S86
  59. Wai CT, Lim LG, Sutedja D, Lee YM, LeeKH, Isaac J, LimSG. Long-term results of liver transplant in patients with chronic viral hepatitis related liver disease in Singapore. Annals of Academy of Medicine, Singapore 2005;34:S86
  60. Wai CT, Lee YM, Sutedja D, Da Costa M, Lee KH, Quak SH, Isaac J, Lim SG. Liver transplantation in Singapore 1990-2004. Annals of Academy of Medicine, Singapore 2005;34:S86
  61. Wai CT, Lim LG, Isaac J, Sutedja D, Wang SC, Lau G, Lim SG. Pre-liver transplant locoablative therapy: a double-edged sword. Annals of Academy of Medicine, Singapore 2005;34:S86
  62. Wong RKM, Lim Sg, Chan YH, Aung MO, Wai CT. Primary biliary cirrhosis: study of a Singaporean population- demographics, prognosis, and factors involving progression. Annals of Academy of Medicine, Singapore 2005;34:S86
  63. Wai CT, Mak B, Aung MO, Lim SG. Age as a determinant on test-and-vaccinate vs. vaccinate-all for hepatitis A immunization. J Gastroenterol Hepatol 2006;21 (Suppl 1): A24
  64. Wai CT, Tan BH, Low MY, Bloodworth BC, Chan CL. Drug induced liver injury in Asia: the importance of adulterated substances in herbs. J Hepatol 2006;44:S266
  65. Wai CT, Mak B, Aung MO, Lim SG. Relationship between seroprevalence of anti-HCV and age: impact on screening before vaccination. J Gastroenterol Hepatol 2006;21 (Suppl2): A100
  66. Lim LG, Cheng CL, Wee A, Lim SG, Lee YM, Sutedja DS, Da Costa M, Prabhakaran K, Wai CT. Benign nature of post-transplant steatosis in patients transplanted for non-NAFLD related liver diseases. J Gastroenterol Hepatol 2006;21 (Suppl2): A198
  67. Y. Lee, CT. Wai, Y. Dan, M. Aung, L. Zhou, S. Lim. A randomized controlled double blind study of Pentoxifylline in patients with Non Alcoholic Steatohepatitis (NASH). Hepatology 2006;44(S1):654A
  68. S.N. Wong, C. Chu, CT Wai, R.J. Fontana, A.S. Lok. Low risk of HBV recurrence post-liver transplantation (OLT) in patients maintained on nucleoside(t)e analogue (NA)therapy after withdrawal of hepatitis B immune globulin (HBIG). Hepatology 2006;44(S1):480A
  69. C. Wai, Y. Dan, S. Lim, M. Aung, Y. Lee, D. Sutedja, M. Aw, S. Quak, M. Lee, M. Da Costa, K. Prabhakaran K. Lee. Restricting MARS® to patients with transplant support: results from 81 patients at a single center. Hepatology 2006;44(S1):364A
  70. S. Lim, B. Mak, D. Sutedja, Y. Lee, Y. Dan, D. Wai, E Koay. Sequential Lamivudine And Adefovir Therapy Maintains Seroconversion Rates In Patients With HBeAg+ Chronic Hepatitis B. Hepatology 2006;44(S1):566 Hepatology 2006;44(S1):364A A
  71. Y. Dan, C. Wai, S. Lim. Modeling for the most cost-effective treatment strategy for eAg positive Chronic Hepatitis B. Hepatology 2006;44(S1):562A
  72. Lim LG, Lim SG, Sutedja D, Dan Y, Lee C, Wai CT. Impact of prophylactic antibiotics in cirrhotic patients presenting with sepsis. Gastroenterology 2007;135(S2):A805 
  73. Low HC, Lim SG, Wai CT. Autoimmune Hepatitis And Traditional Chinese Medication In Singapore. Gastroenterology 2007;135(S2):A770 
  74. Wai CT, Harshal R, Tanveer M, Lee KH, Wong SY, Leong SO, Singh R, Tay KH, Tan KC. Lessons learnt from the first 100 LDLT at a tertiary center. J Gastroenterolo Hepatol 2008;23(S5):A71
  75. Modified Rendezvous technique in management of biliary leak in right lobe live donor liver transplant recipients and donors. C-T WAI, S-S NGOI, P GOH, K-H LEE, M Lin, KC Tan. J Gastroenterol Hepatol 2009;24(S1):A110
  76. HA Woon, CT Wai, KH Lee, S Cecilia, KC Tan. Live donor liver transplant (LDL) as a treatment option for hepatocellular carcinoma (HCC) exceeding UCSF criteria. J Gastroenterol Hepatol 2010;25(S2):A88
  77. HA Woon, CT Wai, KH Lee, S Cecilia, YM Tan, KC Tan. Results of live donor liver transplant (LDLT) at a tertiary liver center. J Gastroenterol Hepatol 2010;25(S2):A89

GRANTS

  1. “Factors associated with advanced fibrosis in patients with chronic hepatitis C” –General Clinical Research Center (GCRC) Grants, University of Michigan, protocol no. 1893, Co-investigator, (US$ 11,175)
  2. Identifying and Overcoming Barriers to Recommended Cancer Screening In the Community- Principal Investigator, NHG SIG grant (S$48,800)

PAPERS PRESENTED IN LOCAL AND INTERNATIONAL CONFERENCES

3rd National University Hospital-Faculty of Medicine Annual Scientific Meeting 1999.

  1. Wai CT. Drug overdose/poisoning in Singapore in the year 1998. (Poster)
  2. Wai CT, Yeoh KG, Ho KY, Lim SG. Upper GI endoscopy for investigation of dyspepsia; Can it be omitted in the young adult? (Poster)

19th Annual Combined Scientific Meeting with 15th Annual Scientific Meeting of the GE Society of Singapore 1999.

  1. Wai CT, Yeoh KG, Ho KY, Lim SG. Audit of 10,488 upper GI endoscopies. (Oral)

6th Congress of the Asian Society of Transplantation 1999.

  1. Wai CT, Lo SK, Lee KH, Tan CK, A MM, Quak SH, Isaac, Prabhakaran K, Lim SG, Tan KC. 10 years experience of liver transplantation in Singapore. (Oral)
  2. Wai CT, Lo SK, Lee KH, Tan CK, Isaac J, Prabhakaran K, Lim SG, Tan KC. Liver transplantation in hepatocellular carcinoma. (Poster)

Asian Pacific Association for the Study of Liver Commemorative International Congress on Viral Hepatitis, Prevention and Control 2000.

  1. Wai CT, Lim SG, Tan CK, Chow WC, Aw MM, Quak SH, Isaac J, Prabhakaran K, Tan KC Analysis of mortality of liver transplantation in Singapore. (Oral)
  2. Wai CT, Lim SG, Lee KH, Tan CK, Chow WC, Isaac J, Prabhakaran K, Tan KC. Use of lamivudine in prevention of hepatitis B recurrence post liver transplant. (Poster)
  3. Wai CT, Lim SG, Lee KH, Tan CK, Chow WC, Isaac J, Prabhakaran K, Tan KC. Liver tranplantation as the treatment of choice for hepatocellular carcinoma. (Poster)
  4. Kaur M, Wai CT, Lee KH, Lim SG, Isaac J, Prabhakaran K, Tan KC. Results of hepatitis C in liver transplant patients. (Poster)

Digestive Disease Week , American Society of GI Endoscopy Meeting 2000.

  1. Wai CT, Yeoh KG, Ho KY, Lim SG. Endoscopic yield in Asian patients presenting with dyspepsia. (Poster)

7th World Congress of Endoscopic Surgery 2000

  1. Wai CT, Ho KY, Yeoh KG, Lim SG. Palliation of malignant gastric outlet obstruction with expansile metal stents. (Poster)
  2. Wai CT, Yeoh KG, Ho KY, Lim SG. Audit of upper GI endoscopies over 7 year period. (Poster)
  3. Wai CT, Yeoh KG, Ho KY, Lim SG. Endoscopic yield in Asian patients presenting with dyspepsia. (Poster)
  4. Wai CT, Yeoh KG, Ho KY, Lim SG. Colonic adenocarcinoma in patients with liver abscess: consider colon screening in elderly patients with no obvious abscess etiology. (Oral)
  5. Wai CT, Yeoh KG, Ho KY, Lim SG. Gastrointestinal carcinoid tumors in Asian patients and the usefulness of endosconography in management. (Oral)
  6. Wai CT, Yeoh KG, Ho KY, Lim SG. Concomitant pathology in upper and lower GI tract in Asian patients presenting with anaemia. (Oral)

American Association of the Study of Liver Diseases Meeting 2000.

  1. Lee HL, Wai CT, Mak K. Post-operative follow-up of living-related liver transplant donors in Singapore. (Poster)
  2. Lim SG, Zhou L, Li L, Tan TMC, Peter F, Ren EC, Delamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Chan SH. An increase in T cell activation and T cell cytotoxic subsets are discriminators of response to treatment with interferon.thymosin in patients with chronic hepatitis B. (Poster)
  3. Lim LL, Wai CT, Lee YM, Pereumal, Chung CK, Koay E, Lai ST, Kong HL, Lim SG. Prophylactic lamivudine prevents hepatitis B reactivation and mortality in patients receiving immunosuppression and chemotherapy. (Poster)

34th Singapore-Malaysia Congress of Medicine 2000

  1. Wai CT, Ho KY, Yeoh KG, Lim SG. Palliation of malignant gastric outlet obstruction with expansile metal stents. (Oral)
  2. Lim LL, Wai CT, Lee YM, Koay, Kong HL, Lim SG. Patients on immunosuppression and chemotherapy should receive prophylactic lamivudine to prevent hepatitis B reactivation and mortality. (Oral)
  3. Lee YM, Sutedja D, Wai CT, Lim LL, Dong D, Perumal V, Chung CK, Lim TP, Ho I, Yeoh KG, Ho KY, Lim SG. The natural history of antiHBe+ve chronic hepatitis B patients. (Oral)
  4. Peter F, Cheng Y, Ong C, Kausalita PJ, Seet BL, Delamat DS, Wai CT, Tan T, Lim SG. No correlation between hepatitis B virus e seorconversion and hot-spot mutations in core promoter and precore sequence of HBV. (Oral)
  5. Lim SG, Zhou L, Li L, Tan TMC, Peter F, Ren EC, Delamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Chan SH. An increase in T cell activation and T cell cytotoxic subsets are discriminators of response to treatment with interferon.thymosin in patients with chronic hepatitis B. (Oral)

16th Annual Scientific Meeting Gastroenterological Society of Singapore 2000

  1. Lim SG, Zhou L, Li L, Tan TMC, Peter F, Ren EC, Delamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Chan SH. An increase in T cell activation and T cell cytotoxic subsets are discriminators of response to treatment with interferon.thymosin in patients with chronic hepatitis B. (Oral)
  2. Lee YM, Sutedja D, Wai CT, Lim LL, Dong D, Perumal V, Chung CK, Lim TP, Ho I, Yeoh KG, Ho KY, Lim SG. The natural history of antiHBe+ve chronic hepatitis B patients. (Oral)
  3. Lim LL, Wai CT, Lee YM, Pereumal, Chung CK, Koay E, Lai ST, Kong HL, Lim SG. Prevention of hepatitis B reactivation and mortality in patients receiving immunosuppression and chemotherapy with prophylactic lamivudine. (Oral)
  4. Peter F, Cheng Y, Ong C, Kausalita PJ, Seet BL, Wai CT, Tan T, Lim Sg. New molecular changes in the hepatitis B viral genome following HBV e seroconversion (Oral)
  5. Lim SG, Zhou L, Li L, Tan T, Peter F, Ren EC, Selamat DS, Wai CT, Lim LL, Lee yM, Perumal V, Chan SH. T cell cytokine release to HBs, HBc and Hbe antigens before and after treatment with interferon/thymosin in patients with chronic hepatitis B. (Poster)
  6. Lim SG, Zhou L, Li L, Tan T, Ren EC, Selamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Peter F. Increased T cell proliferation to HBs, HBC, HBE-antigens are distriminators of response to treatment with interferon/thymosin in patients with chronic hepatitis B. (Poster)
  7. Lim SG, Perumal V, Peter F, Tan T, Lee YM, Selamat DS, Wai CT, Lim LL, Leow CL, Chiu L, Kooh MJ, Koay E. Performance of the Digene hybrid capture HBV DNA assay compared to Abbott hybridization HBV DNA assay, and development of a conversion formula. (Poster)
  8. Wai CT, Lim SG, Tan CK, Lee KH, Chow WC, Prahbakaran K, Tan KC. Favourable outcome of liver transplantation in patients with hepatitis B virus related liver diseases despite emergence of lamivudine resistant virus. (Poster)
  9. Wai CT, Ho KY, Yeoh KG, Lim SG. Through the scope endoscopic self-expansile metal stenting as means of palliation for malignant gastric outlet obstruction. (Poster)

Australian Digestive Disease Week 2000

  1. Lim SG, Zhou L, Li L, Tan TMC, Peter F, Ren EC, Delamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Chan SH. An increase in T cell activation and T cell cytotoxic subsets are discriminators of response to treatment with interferon.thymosin in patients with chronic hepatitis B. (Oral)
  2. Peter F, Cheng Y, Ong C, Kausalita PJ, Seet BL, Wai CT, Tan T, Lim SG. Hepatitis B e-seroconversion correlates with clustered changes in the core promoter and enhancer II region of HBV. (Oral)
  3.  Lim SG, Zhou L, Li L, Tan T, Ren EC, Selamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Peter F. Increased T cell proliferation to HBs, HBC, HBE-antigens are distriminators of response to treatment with interferon/thymosin in patients with chronic hepatitis B. (Poster)
  4. Peter F, Cheng Y, Ong C, Kausalita PJ, Seet BL, Selamat DS, Wai CT, Tan T, Lim SG. No correlation between hepatitis B virus e-seroconversion and hot-spot mutation in core promoter and precore sequence of HBV. (Poster)
  5. Lim SG, Perumal V, Peter F, Tan T, Lee YM, Selamat DS, Wai CT, Lim LL, Leow CL, Chiu L, Kooh MJ, Koay E. Performance of the Digene hybrid capture HBV DNA assay compared to Abbott hybridization HBV DNA assay, and development of a conversion formula. (Poster)
  6. Lim LL, Wai CT, Lee YM, Pereumal, Chung CK, Koay E, Lai ST, Kong HL, Lim SG. Prevention of hepatitis B reactivation and mortality in patients receiving immunosuppression and chemotherapy with prophylactic lamivudine. (Oral)
  7. Lim SG, Zhou L, Li L, Tan T, Peter F, Ren EC, Selamat DS, Wai CT, Lim LL, Lee yM, Perumal V, Chan SH. T cell cytokine release to HBs, HBc and Hbe antigens before and after treatment with interferon/thymosin in patients with chronic hepatitis B. (Poster)
  8. Lee YM, Selamat DS, Wai CT, Lim LL, Dong F, Perumal V, Chung CK, Lim TP, Ho I, Yeoh KG, Ho KY, Lim SG. The natural history of anti-Hbe +ve chronic hepatitis B patients. (Oral)

3rd UICC Cancer Management Meeting 2001

  1. Wai CT, Lim SG, Lee KH, Tan CK, Isaac J, Prabhakaran K, Tan KC. Liver transplantation is an effective treatment for unresectable hepatocellular carcinoma. (Oral)
  2. Wai CT, Ho KY, Yeoh KG, Lim SG. Self-expansile metal stenting is an effective means for palliation for malignant gastric outlet obstruction. (Oral)
  3. Lim LL, Wai CT, Lee YM, Kong HL, Koay E, Lim SG. Prophylactic lamivudine prevents hepatitis B reactivation and mortality in patients receiving chemotherapy. (Oral)

Singapore 15-17 Feb 2001Helicobacter and Viral Hepatitis, Sheraton Towers, Singapore

15-17 Feb 2001

  1. Ong C, Lim SG, Perumal V, Peter F, Tan T,  Lee YM, Wai CT, Lim LL, Leow CL, Chiu L, Kooh MJ, Koay E. Performance of the Digene Hybrid Capture HBV DNA assay compared to Abbott Hybridisation HBV DNA assay, and development of a conversion formula. (Oral)
  2. Lee YM, Selamat DS, Wai CT, Lim LL, Dong F, Perumal V, Chung CK, Lim TP, Ho I, Yeoh KG, Ho KY, Lim SG. The natural history of anti-Hbe +ve chronic hepatitis B patients. (Oral)
  3. Lim SG, Zhou L, Li L, Tan T, Peter F, Ren EC, Selamat DS, Wai CT, Lim LL, Lee YM, Perumal V, Chan SH. T cell cytokine release to HBs, HNc and Hbe antigens before and after treatment with interferon/thymosin in patients with chronic hepatitis B. (Poster)
  4. Peter F, Cheng Y, Ong C, Kausalita PJ, Seet BL, Selamat DS, Wai CT, Tan T, Lim SG. No correlation between hepatitis B virus e seroconversion and hot spot mutations in core promoter and precore sequence of HBV. (Poster)
  5. Lim LL, Wai CT, Lee YM, Kong HL, Koay E, Lim SG. Prevention of hepatitis B reactivation and mortality in patients receiving immunosuppression and chemotherapy with prophylactic lamivudine. (Poster)

36th  Annual Meeting of European Association for the Study of Liver (EASL), Prague

 17-22 April, 2001

  1. Wai CT, Chan E, Lee YM, Lim LL, Lim SG. Prognostic factors for acute exacerbation of chronic hepatitis B in Asian patients. (Poster)
  2. Lim SG, Zhou L, Li L, Tan T, Peter F, Ren EC, Selamat DS, Wai CT, Lim LL, Lee Ym. T cell immune response during HbeAg seroconverson-evidence of T cell activation, cytotoxicity and proliferation during treatment with interferon/thymosin in patients with chronic hepatitis B. (Poster)

5th NUH-NUS Faculty of Medicine Annual Scientific Meeting. 29-30 June 2001.

  1. Wai CT, The Ming, Seet BL, Ho Bow, Yeoh KG. Gastric cancer is associated with reduced apoptosis in gastric mucosa irregardless of Helicobacter pylori infection. (Oral Paper, shortlisted for Young Doctor Award)

Asia Pacific Digestive Week 2001, 23-27 Sept 2001, Sydney, Australia.

  1. Wai CT, Ho KY, Leong A, Kum CK. Stent Migration as a potential complication of metallic stent placement in patients with inoperable colorectal cancer. (Poster)
  2. Wai CT, Teh M, Seet BL, Ho B, Yeoh KG. Helicobacter pylori is directly involved in inflammatory gastric mucosa damage throughout the nitric oxide pathway but not directly related to apoptosis. (Poster)
  3. Gwee KA, Wai CT Wong ML, Goh LG. Epidemiology of irritable bowel syndrome in an Asian urban society. (Poster)
  4. Wai CT, Gwee KA, Goh LG, Mak B. Treatment expectations, satisfaction and preferences of IBS patients seen by general practitioners. (Oral)
  5. Wai CT, DaCosta M, Lim SG, Tan KC, Lee KH. Liver dialysis in Singapore. (Oral)
  6. Dan YY, Lee YM, Lim LL, Wai CT, Lim SG. Clinical pathogenicity of lamivudine resistant hepatitis B virus is related to the pre-treatment (wildtype) status. (Oral)
  7. Lee YM, Suteja DD, Wai CT, Wong LS, Chan E, Lim SG. The natural history of HbeAg positive and anti-Hbe positive chronic hepatitis B patients – a long term study. (Oral)

52nd Annual Meeting of the American Association for the Study of Liver Diseases, Dallas, 2001.

  1. Wai CT, E Chan, Lee YM, Lim LL, Lim SG. Rising prothrombin time is the sole prognostic factor for flare of chronic hepatitis B in Asian patients. (Poster)

17th Annual Scientific Meeting, Gastroenterological Society of Singapore, 2001

  1. Wai CT, Teh M, Seet BL, Ho B, Yeoh KG. Gastric cancer is associated with reduced apoptosis in gastric mucosa irregardless of Helicobacter pylori infection. (Oral)
  2. Wai CT, Gwee KA, Goh LG, Mak B. Treatment prevalence for IBS patients in the primary care setting. (Oral)

World Congress of Gastroenterology 2002/ 2nd Asia Pacific Digestive Disease Week, Bangkok, 2002.

  1. Wai CT, Gwee KA, Wong ML, Png D. Is irritable bowel related to irritable bladder (Poster)
  2. Wai CT, Thambyah PA. False positive HIV-Elisa in patients with acute hepatitis B or acute exacerbation of chronic hepatitis B (Poster)
  3. Wai CT, Teh Ming, Seet BL, Ho B, Yeoh KG. Helicobacter pylori infection does not induce apoptosis through increasing induced nitric oxide synthase (Poster). 

53rd Annual Meeting, the American Association for the Study of Liver Diseases, Boston, 2002.

  1. Wai CT, Chu CJ, Munira H, Lok ASF. HBV Genotype B is associated with a higher response rate to interferon therapy than Genotype C. (Oral)
  2. Chu CJ, Fontana RJ, Moore C, Wai CT, Punch J, Su G, Lok AS. Efficacy of HBIG weaning in the long-term prophylaxis of HBV reinfection following liver transplantation. (Oral)

Digestive Disease Week, Orlando, 2003

  1. Wai CT, Greenson JK, Fontana R, Kalbfleisch K, Marrero J, Conjeevaram HS, Lok A. A Novel non-invasive index is useful in excluding both significant fibrosis and cirrhosis in chronic hepatitis C (CHC) patients. (Poster)
  2. Yeoh KG, Wai CT, The M, Tan KB, Seet BL, Rajnakova A. Gastric cancer is associated with reduced apoptosis in non-lesional gastric mucosa rather than increased mucosal proliferation. (Poster)

8th Congress of Asian Society of Transplantation, Kuala Lumpur, 2003

  1. Wai CT, Prabhakaran K, YM Lee, Dan YY, Sujtedja DS, Isaac J, Lee KH, Lee HL, Lee M, Da Costa M, Lim SG. Adefovir dipivoxil (ADV) as the rescue therapy for lamivudine (LAM) resistant hepatitis B post liver transplant (Oral)
  2. Wai CT, K Prabhakaran, M Kaur, Lee YM, Dan YY, Sutjedta D S, MM Aw, Quak SH, Mak K, Isaac J, KH Lee, SG Lim. Successful listing of patients for liver transplant was related to paricipation of referring doctor in the transplant program. (Poster)
  3. Sutedja D S, Wai CT, Teoh KF , Lee HL , DaCosta M, Lee M, Kaur M, Lee YM, Mak K, Isaac J, Lee KH, Lim SG, Prabhakaran K. Persistent thrombocytopenia in liver transplanted patients. (Poster)
  4. Sutedja D S, Wai CT, Teoh KF , Lee HL , DaCosta M, Lee M, Kaur M, Lee YM, Mak K, Isaac J, Lee KH, Lim SG, Prabhakaran K. Renal impairment and diabetes mellitus after liver transplantation. (Poster)

3rd Asia Pacific Digestive Disease Week, Singapore, 2003

  1. Wai CT, Perumal V, Mak B, Chua W, Lam C, Lim SG. Inclusion of young patients in surveillance program for hepatitis B. (Poster)

54th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, 2003.

  1. Mak B, Wai CT, Chen MH, Lim SG. Informed consent and clinical trials for chronic hepatitis B in Asia: Do patients understand the concepts? (Poster)
  2. Wai CT, Fontana RJ, Schilsky M, McCashland T, Han St,
  3. Polson J, Hussain M, Lee WM, Lok AS. Molecular epidemiology of hepatitis B virus-related acute liver failure in the United States: a multicenter case control study. (Poster)

4th Asia Pacific Digestive Week, Beijing, 2004

  1. Wai CT, Mak B, Chua W, Lim SG. Screening of compliance among hepatitis B carriers in Singapore. (Oral, shortlisted for Young Investigator’s Award)

NHG Annual Scientific Meeting, 2004

  1. Lu W, Wai CT, Da Costa M, Tambyah PA, Prabhakaran K, Lee KH. Tuberculosis post liver tranplantation: a rare but complicated disease. (Poster)

APASL Meeting 2004 , New Dehli, India

  1. Wai CT, Sutedja D, Da Costa M, Lee YM, Isacc J, Prabhakaran K, Lim SG. Long-term results of liver transplant in patients with chronic viral hepatitis and related liver diseases. (Poster)
  2. Wai CT, Lim SG. Herbal medicines is an important cause for drug induced liver injuries (DILI). (Poster)
  3. Teoh KF, Wai CT, Aung MO, Da Costa M, Lee HL, Isaac J, Lim SG. Epidemiology of acute liver failure in Singapore (Poster)
  4. Lu W, Wai CT, Da Costa, Tambyah PA, Prabhakaran K, Lee KH. A case report on tuberculosis post liver transplantation. (Poster)

Digestive Disease Week, Chicago, May 2005

  1. Wai  CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Aung MO, Lim SG. A Novel Non Invasive Marker Can Exclude Cirrhosis in Chronic Hepatitis B. (Poster), abstract no. M944
  2. Teoh KF, Wai CT, Maureen Da Costa, Isaac J, Lim SG. Drug induced liver failure in Asia. (Poster) abstract no. S1496

Asian Pacific Association for the Study of Liver Disease, Bali, 2005

  1. RKM Wong, SG Lim, YH Chan, MO Aung, CT Wai. Primary biliary cirrhosis in an Asian population: a natural history study. (1st runner up in Young Investigator Award)
  2. Chun-Tao Wai, How-Cheng Low, Maureen Da Costa, John Isaac and Seng-Gee Lim. Impact of new legislation on the number of liver transplants in Singapore (Poster)

American Association for the Study of Liver Diseases Single Topic Conference, Atlanta, USA, 2005

  1. CT Wai, BH Tan, MY Low, BC Bloodworth, CL Chan, A Cheok, SG Lim. Traditional Chinese medicines in drug induced liver injury (Poster)

16th Conference of the Asian Pacific Association for the Study of the Liver, Manila 2006

  1. Wai CT, Mak B, Aung MO, Lim SG. Age as a determinant on test-and-vaccinate vs. vaccinate-all for hepatitis A immunization. (Oral)

Shanghai-Hong Kong International Liver Conference, Shanghai, 2006

  1. Lim LG, Cheng CL, Wee A, Lim SG, Lee YM, Sutedja DS, Da Costa M, Prabhakaran K, Wai CT. Benign nature of post-transplant steatosis in patients transplanted for non-NAFLD related liver diseases. (Poster)
  2. Wai CT, Mak B, Aung MO, Lim SG. Relationship between seroprevalence of anti-HCV and age: impact on screening before vaccination. (Poster)

European Association of Study of Liver Disease, Vienna, 2006

  1. Wai CT, Tan BH, Low MY, Bloodworth BC, Chan CL. Drug induced liver injury in Asia: the importance of adulterated substances in herbs. (Poster)

14th United European Gastroenterology Week (UEGW 2006), Berlin.:

  1. H. Low, M. Lee, S. Lim, K. Lee, D. S. Sutedja, Y. Lee, Y. Dan, M. Da Costa,  K Prabhakaran, C. Wai. Poor prognosis of acute liver failure from hepatitis B flares despite MARS® treatment. (Poster)

57th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, 2006.

  1. Y. Lee, CT. Wai, Y. Dan, M. Aung, L. Zhou, S. Lim. A randomized controlled double blind study of Pentoxifylline in patients with Non Alcoholic Steatohepatitis (NASH). (Poster)
  2. S.N. Wong, C. Chu, CT Wai, R.J. Fontana, A.S. Lok. Low risk of HBV recurrence post-liver transplantation (OLT) in patients maintained on nucleoside(t)e analogue (NA)therapy after withdrawal of hepatitis B immune globulin (HBIG). (Poster)
  3. C. Wai, Y. Dan, S. Lim, M. Aung, Y. Lee, D. Sutedja, M. Aw, S. Quak, M. Lee, M. Da Costa, K. Prabhakaran K. Lee. Restricting MARS® to patients with transplant support: results from 81 patients at a single center. (Poster)
  4. S. Lim, B. Mak, D. Sutedja, Y. Lee, Y. Dan, D. Wai, E Koay. Sequential Lamivudine And Adefovir Therapy Maintains Seroconversion Rates In Patients With HBeAg+ Chronic Hepatitis B (Poster)
  5. Y. Dan, C. Wai, S. Lim. Modeling for the most cost-effective treatment strategy for eAg positive Chronic Hepatitis B. (Poster)
Digestive Disease Week, Washington DC, USA May 2007
  1. L. Lim; S. Lim; D. Sutedja; Y. Dan; Y. Lee; C. Wai Impact of prophylactic antibiotics in cirrhotic patients presenting with sepsis.  (Poster)
  2.   H. Low; S. Lim; C. Wai Autoimmune Hepatitis And Traditional Chinese Medication In Singapore.  (Poster)

Congress of Asian Society of Transplant 2008

  1. Wai CT, et al. Experience of transplant team an important factor for posttransplant survival in patients with HCC undergoing live donor liver transplant (Poster)
  2. Wai CT, et al. Prognostic factors for patients with Acute Liver Failure undergoing Live Donor Liver Transplant (Poster)

4th Liver Update, Jakarata, organized by Indonesia Association of Study of Liver Disease, June 2008

  1. Management of Post transplant patients (Oral)
  2.  Management of Ascites (Oral)

Asia Pacific Digestive Week, Delhi, Indian, 2008

  1. Lessons learnt in 100 live donor liver transplants (Poster)

Asia Pacific Digestive Week, Taipei City, Taiwan, 2010 (Poster)

  1. Modified Rendezvous technique in management of biliary leak in right lobe live donor liver transplant recipients and donors. C-T WAI, S-S NGOI, P GOH, K-H LEE, M Lin, KC Tan.

Asia Pacific Digestive Week, KL, Malaysia, 2010 (Posters)

  1. HA Woon, CT Wai, KH Lee, S Cecilia, KC Tan. Live donor liver transplant (LDL) as a treatment option for hepatocellular carcinoma (HCC) exceeding UCSF criteria. J Gastroenterol Hepatol 2010;25(S2):A88
  2. HA Woon, CT Wai, KH Lee, S Cecilia, YM Tan, KC Tan. Results of live donor liver transplant (LDLT) at a tertiary liver center 2010;25(S2):A89

Congress of Asian Society of Transplant Seoul, South Korea, 2011

  1. CT Wai, WA Woon, KH Lee, YM Tan, KC Tan. Pretransplant meld score has no impact on post transplant survival in live donor liver transplantation (IDLT) (Oral)
  2. CT Wai, WA Woon, YM Tan, KH Lee, KC Tan. YOUNGER AGE AND PRESENCE OF MACROVASCULAR INVASION WERE INDEPENDENT SIGNIFICANT FACTORS ASSOCIATED WTH POOR DISEASE-FREE SURVIVAL IN HEPATOCELLULAR CARCINOMA PATIENTS UNDERGOING LIVE DONOR LIVER TRANSPLANT (Poster).